A new case report out of Europe shows a man’s severe tics from Tourette Syndrome (TS) were dramatically reduced after he began using Nabiximols, an oromucosal spray containing various cannabinoids.
Story continues below
This advertisement has not loaded yet, but your article continues below.
“Based on our case, and in line with previous reports, we propose that buccal Nabiximols might be an effective addition to ‘acute’ or ‘as required’ tic treatment under specialist guidance,” authors of the case report write.
This will especially be the case “for predictable situations in the short term when severely disabling or stigmatizing tics are anticipated,” they note in the report published last month.
Containing a standardized extract of THC, CBD, other minor
Read full article on The Growth Op
